Use of inhaled ciclesonide for treatment of moderate asthma in Thoroughbred racehorses
Treatment with inhaled ciclesonide improved clinical signs and decreased BALF mastocytic inflammation in racehorses with moderate asthma without change in the environment. Treatment effect on neutrophilic or eosinophilic asthma remains undetermined. The small number of horses was a study limitation.
Authors
- Jenyka Bergsma
- Warwick M. Bayly (ORCID: https://orcid.org/0000-0002-1403-6245)
- Macarena G. Sanz (ORCID: https://orcid.org/0000-0001-6565-9947)
- Myeounghoon Cha (ORCID: https://orcid.org/0000-0002-7993-672X)
- Gordon Kordas (ORCID: https://orcid.org/0000-0003-1925-5225)
- Gina Jellen
- Renaud Léguillette (ORCID: https://orcid.org/0000-0003-0381-3640)
- Clark Kogan (ORCID: https://orcid.org/0000-0001-8989-0350)
- Lauren Cody
Institutions
- Atkins (United States) (US)
- University of Nevada, Reno (US)
- University of Calgary (CA)
- Statkraft (Norway) (NO)
- MEP Equine Solutions (United States) (US)
- Craft Engineering Associates (United States) (US)
- Statistical Service (CY)
- Computercraft (United States) (US)
- Washington State University (US)
Publication Details
- Journal
- Journal of Veterinary Internal Medicine
- Published
- 2025-02-13
- DOI
- https://doi.org/10.1111/jvim.17267
- Citations
- 1
- Primary Topic
- Veterinary Equine Medical Research
- Type
- article
- Field-Weighted Citation Impact
- 2.73
Funders
- Washington State University
- University of Calgary
- Universities Space Research Association
- Natural Sciences and Engineering Research Council of Canada